{"id":1615,"date":"2016-12-02T17:34:48","date_gmt":"2016-12-02T17:34:48","guid":{"rendered":"https:\/\/www.delveinsight.com\/blog\/?p=1615"},"modified":"2025-05-05T09:49:10","modified_gmt":"2025-05-05T04:19:10","slug":"sjogrens-syndrome-autoimmune-attack-on-salivary-and-tear-glands","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/sjogrens-syndrome-autoimmune-attack-on-salivary-and-tear-glands","title":{"rendered":"Sjogren’s syndrome- Autoimmune Attack on Salivary and Tear Glands"},"content":{"rendered":"

Sj\u00f6gren’s syndrome<\/a> was named on Henrik Sj\u00f6gren\u00a0who described this indication in 1933, and is a chronic autoimmune disease in which body\u2019s own immune system and white blood cells attack moisture producing glands such as tear and salivary glands, leading to dry mouth and eyes. There are certain other symptoms involved, such as chronic cough, dryness of skin, vaginal dryness, numb feeling in arms and legs, muscles and joint pains and problems related to thyroid.<\/p>\n

The number of patients suffering from sjogren\u2019s syndrome is increasing and so is the awareness about the syndrome. All this is leading to an increased demand for advanced treatment of this disease. Growing geriatric population, increasing research and development activities and government initiative are some of the factors that drive the growth of the sjogren\u2019s syndrome treatment market. At present, there are around 20+ pipeline drugs for this indication with only 2 drugs in Phase III trials, while majority of the drugs are in Phase II stage of development. Rigorous research and development activities are being conducted to help launch innovative treatments.<\/p>\n

Companies operating in conditions related to dry eye conditions are the ones entering into mergers and acquisitions with other companies, to expand their product offerings. In 2014, Nicox S.A., a French company, launched AdenoPlus, a medical device for the detection of adenoviral conjunctivitis, as well as Xailin, a range of tear lubricant products. 2015 saw Allergan plc completing its acquisition of Oculeve Inc. to develop its business in the dry eye syndrome treatment market. Apart from this acquisition, Allergan, Inc. also introduced synthetic tear Refresh Optive<\/em> gel drops to deliver artificial tear alternative for relieving dry eye symptoms. Global sjogren\u2019s syndrome treatment market<\/a> is anticipated to register a healthy CAGR. It is anticipated that Asia-Pacific region is a prospective market for sjogren\u2019s syndrome treatment because of growing healthcare infrastructure, increase in disposable income and an increasing number of patients suffering from autoimmune diseases which might lead to sjogren\u2019s syndrome.<\/p>\n

Insight by:<\/em>
\nAnurag Mathur<\/em>
\nAssociate Analyst<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

Sj\u00f6gren’s syndrome was named on Henrik Sj\u00f6gren\u00a0who described this indication in 1933, and is a chronic autoimmune disease in which body\u2019s own immune system and white blood cells attack moisture producing glands such as tear and salivary glands, leading to dry mouth and eyes. There are certain other symptoms involved, such as chronic cough, dryness […]<\/p>\n","protected":false},"author":1,"featured_media":1616,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17],"tags":[674,675,382,464,673],"industry":[17225],"therapeutic_areas":[17227],"class_list":["post-1615","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","tag-eye-dryness","tag-healthcare","tag-market-scenario","tag-pharma","tag-sjogrens-syndrome","industry-pharmaceutical","therapeutic_areas-immunological-and-autoimmune-disorders"],"acf":[],"yoast_head":"\nSjogren's syndrome- Autoimmune Attack on Salivary and Tear Glands<\/title>\n<meta name=\"description\" content=\"Sj\u00f6gren's syndrome was named on Henrik Sj\u00f6gren\u00a0who described this indication in 1933 and is a chronic autoimmune disease in which body...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/sjogrens-syndrome-autoimmune-attack-on-salivary-and-tear-glands\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sjogren's syndrome- Autoimmune Attack on Salivary and Tear Glands\" \/>\n<meta property=\"og:description\" content=\"Sj\u00f6gren's syndrome was named on Henrik Sj\u00f6gren\u00a0who described this indication in 1933 and is a chronic autoimmune disease in which body...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/sjogrens-syndrome-autoimmune-attack-on-salivary-and-tear-glands\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-12-02T17:34:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-05T04:19:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2016\/12\/09180506\/eye.png\" \/>\n\t<meta property=\"og:image:width\" content=\"464\" \/>\n\t<meta property=\"og:image:height\" content=\"264\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Sjogren's syndrome- Autoimmune Attack on Salivary and Tear Glands","description":"Sj\u00f6gren's syndrome was named on Henrik Sj\u00f6gren\u00a0who described this indication in 1933 and is a chronic autoimmune disease in which body...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/sjogrens-syndrome-autoimmune-attack-on-salivary-and-tear-glands","og_locale":"en_US","og_type":"article","og_title":"Sjogren's syndrome- Autoimmune Attack on Salivary and Tear Glands","og_description":"Sj\u00f6gren's syndrome was named on Henrik Sj\u00f6gren\u00a0who described this indication in 1933 and is a chronic autoimmune disease in which body...","og_url":"https:\/\/www.delveinsight.com\/blog\/sjogrens-syndrome-autoimmune-attack-on-salivary-and-tear-glands","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2016-12-02T17:34:48+00:00","article_modified_time":"2025-05-05T04:19:10+00:00","og_image":[{"width":464,"height":264,"url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2016\/12\/09180506\/eye.png","type":"image\/png"}],"author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/sjogrens-syndrome-autoimmune-attack-on-salivary-and-tear-glands","url":"https:\/\/www.delveinsight.com\/blog\/sjogrens-syndrome-autoimmune-attack-on-salivary-and-tear-glands","name":"Sjogren's syndrome- Autoimmune Attack on Salivary and Tear Glands","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/sjogrens-syndrome-autoimmune-attack-on-salivary-and-tear-glands#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/sjogrens-syndrome-autoimmune-attack-on-salivary-and-tear-glands#primaryimage"},"thumbnailUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2016\/12\/09180506\/eye.png","datePublished":"2016-12-02T17:34:48+00:00","dateModified":"2025-05-05T04:19:10+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"Sj\u00f6gren's syndrome was named on Henrik Sj\u00f6gren\u00a0who described this indication in 1933 and is a chronic autoimmune disease in which body...","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/sjogrens-syndrome-autoimmune-attack-on-salivary-and-tear-glands"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/sjogrens-syndrome-autoimmune-attack-on-salivary-and-tear-glands#primaryimage","url":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2016\/12\/09180506\/eye.png","contentUrl":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2016\/12\/09180506\/eye.png","width":464,"height":264},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":"https:\/\/assets.delveinsight.com\/blog\/wp-content\/uploads\/2016\/12\/09180506\/eye-300x171.png","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Articles<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Articles<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Eye dryness<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Healthcare<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Market Scenario<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Pharma<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Sjogren's syndrome<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Eye dryness<\/span>","<span class=\"advgb-post-tax-term\">Healthcare<\/span>","<span class=\"advgb-post-tax-term\">Market Scenario<\/span>","<span class=\"advgb-post-tax-term\">Pharma<\/span>","<span class=\"advgb-post-tax-term\">Sjogren's syndrome<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 9 years ago","modified":"Updated 1 year ago"},"absolute_dates":{"created":"Posted on Dec 2, 2016","modified":"Updated on May 5, 2025"},"absolute_dates_time":{"created":"Posted on Dec 2, 2016 5:34 pm","modified":"Updated on May 5, 2025 9:49 am"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/1615","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=1615"}],"version-history":[{"count":1,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/1615\/revisions"}],"predecessor-version":[{"id":31608,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/1615\/revisions\/31608"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media\/1616"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=1615"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=1615"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=1615"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=1615"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=1615"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}